Safety of Short Hydration Method for Cisplatin Administration Compared With Conventional Hydration

Inclusion Criteria: * Cancer patient who has plan to receive first cycle of cisplatin \>= 60 mg/m2 * Normal serum creatinine and creatinine clearance \>= 50 ml/min * Age \< 75 years old * Serum albumin \>= 3 g/dl * Plan to receive optimal antiemetic regimen consisting of olanzapine or neurokinase 1 receptor antagonist Exclusion Criteria: * The patient who receives other chemotherapy with adminstration volume higher than 500 ml * Prior heart failure or known left ventricular ejection fraction \> 50% * Prior renal dysfunction within 3 months * Uncontrolled renal disease * current use of diuretic or non-steroidal anti-inflammatory drug (NSAIDs) or starting angiotensin converting enzyme inhibitor (ACEI) or angiotensin receptor blockade (ARB) within 3 months